JAZZ - Is Jazz Pharmaceuticals a Top Stock to Buy Now?
Biotech companies working on vaccines or treatments for COVID-19 have been grabbing much attention from pundits and analysts. But for investors, it's important to remember that there are companies within this industry that are not directly involved in the fight against the coronavirus -- but are still worth serious consideration.
One such biotech is Jazz Pharmaceuticals (NASDAQ: JAZZ) . Shares of this company haven't performed well of late -- they are down by 6.9% year to date, compared with the S&P 500 's meager 1.6% gain in the same period. Despite underperforming the broader market, there are good reasons to add Jazz Pharma to your portfolio; let's discuss some of these reasons.
For further details see:
Is Jazz Pharmaceuticals a Top Stock to Buy Now?